| 828 | 3 | 25 |
| 下载次数 | 被引频次 | 阅读次数 |
胰腺癌是消化系统极具侵袭性的恶性肿瘤。其中局部肿瘤的治疗方式主要是手术切除,但适应证过于苛刻。对于晚期胰腺癌,化疗是标准疗法,但患者副作用严重且会产生耐药性。胰腺癌肿瘤微环境中的肿瘤相关巨噬细胞是含量最高的免疫细胞,在肿瘤发展和化学耐药中起着非常重要的作用。抗肿瘤相关巨噬细胞治疗显示出一定的治疗潜力。因此本文对肿瘤相关巨噬细胞在胰腺癌中的作用机制及肿瘤相关巨噬细胞靶向治疗的研究进展作一综述。
Abstract：Pancreatic cancer is a highly aggressive malignant tumor of the digestive system. Surgical resection is the main treatment of local tumors, but the indications are too strict.For advanced pancreatic cancer, chemotherapy is the standard treatment, but patients have severe side effects and develop drug resistance.Tumor-associated macrophages in the tumor microenvironment of pancreatic cancer are the most abundant immune cells and play a very important role in tumor development and chemoresistance.Antitumor-associated macrophage therapy has shown some therapeutic potential.Therefore, this article reviews the role of tumor-associated macrophages in the pathogenesis of pancreatic cancer and the mechanism of tumor-associated macrophage targeted therapy.
1 Siegel RL,Miller KD,Jemal A.Cancer statistics,2016 [J].CA:A Cancer J Clinicians,2016,66(1):7-30.
2 Aier I,Semwal R,Sharma A,et al.A systematic assessment of statistics,risk factors,and underlying features involved in pancreatic cancer [J].Cancer Epidemiology,2019,58:104:110.
3 Erkan M,Hausmann S,Michalski CW,et al.The role of stroma in pancreatic cancer:diagnostic and therapeutic implications [J].Nat Rev Gastroenterol Hepatol,2012,9(8):454-467.
4 Hu H,Hang JJ,Han T,etal.The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer [J].Tumour Biology :J Int Society Oncodevelopmental Biol Med,2016,37(7):8657-8664.
5 Mantovani A,Sica A.Macrophages,innate immunity and cancer:Balance,tolerance,and diversity [J].Current Opinion Immunol,2010,22(2):231-237.
6 阴克强,王文湛,双卫兵.膀胱癌抗巨噬细胞治疗的研究进展 [J].泌尿外科杂志(电子版),2019,11(2):28-35.
7 Zhu Y,Herndon JM,Sojka DK,et al.Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression [J].Immunity,2017,47(2):323-386.
8 Muhlberg L,Kuhnemuth B,Costello E,et al.miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer [J].Oncoimmunology,2016,5(6):e1160181.
9 Solinas G,Germano G,Mantovani A,et al.Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation [J].J Leukocyte Biol,2009,86(5):1065-1073.
10 Ye H,Zhou Q,Zheng S,et al.Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma [J].Cell Death Dis,2018,9(5):453.
11 Yang L,Zhang Y.Tumor-associated macrophages:from basic research to clinical application [J].J Hematol Oncol,2017,10(1):58.
12 Lesina M,Kurkowski MU,Ludes K,et al.Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer [J].Cancer Cell,2011,19(4):456-469.
13 Kim S,Takahashi H,Lin WW,et al.Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis [J].Nature,2009,457(7225):102:106.
14 Nielsen SR,Schmid MC.Macrophages as key drivers of cancer progression and metastasis [J].2017,2017:9624760.
15 Penny HL,Sieow JL,Adriani G,et al.Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma [J].Oncoimmunology,2016,5(8):e1191731.
16 Helm O,Held-feindt J,Grage-griebenow E,et al.Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis [J].Int J Cancer,2014,135(4):843-861.
17 Kimsey TF,Campbell AS,Albo D,et al.Co-localization of macrophage inflammatory protein-3alpha (Mip-3alpha) and its receptor,CCR6,promotes pancreatic cancer cell invasion [J].Cancer J (Sudbury,Mass),2004,10(6):374-380.
18 Liu B,Jia Y,Ma J,et al.Tumor-associated macrophage-derived CCL20 enhances the growth and metastasis of pancreatic cancer [J].Acta biochimica et biophysica Sinica,2016,48(12):1067-1074.
19 Liu CY,Xu JY,Shi XY,et al.M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells,partially through TLR4/IL-10 signaling pathway [J].J Technical Methods Pathol,2013,93(7):844-854.
20 Chen SJ,Lian GD,Li JJ,et al.Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL-8 [J].2018,7(11):5679-5690.
21 Wang X,Luo G,Zhang K,et al.Hypoxic Tumor-Derived exosomal miR-301a mediates M2 macrophage polarization via PTEN/PI3Kgamma to promote pancreatic cancer metastasis [J].Cancer Res,2018,78(16):4586-4598.
22 Qian BZ,Pollard JW.Macrophage diversity enhances tumor progression and metastasis [J].Cell,2010,141(1):39-51.
23 Dineen SP,Lynn KD,Holloway SE,et al.Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice [J].Cancer Res,2008,68(11):4340-4346.
24 Feng R,Morine Y,IkemotoT,et al.Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction [J].Cell Communication and Signaling :CCS,2018,16(1):54.
25 Shen Z,Seppanen H,Kauttu T,et al.Vasohibin-1 expression is regulated by transforming growth factor-beta/bone morphogenic protein signaling pathway between tumor-associated macrophages and pancreatic cancer cells [J].J Interferon Cytokine Research :Official J Int Society for Interferon and Cytokine Res,2013,33(8):428-433.
26 D'alincourtsalazar M,Manuel ER,Tsai W,et al.Evaluation of innate and adaptive immunity contributing to the antitumor effects of PD1 blockade in an orthotopic murine model of pancreatic cancer [J].Oncoimmunology,2016,5(6):e1160184.
27 Saio M,Radoja S,Marino M,et al.Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide [J].Journal of immunology (Baltimore,Md :1950),2001,167(10):5583-5593.
28 Zhang Y,Velez-delgado A,Mathew E,et al.Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer [J].Gut,2017,66(1):124-136.
29 Kusmartsev S,Gabrilovich DI.STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion [J].J Immunol (Baltimore,Md :1950),2005,174(8):4880-4891.
30 Murray PJ,Wynn TA.Protective and pathogenic functions of macrophage subsets [J].Nat Rev Immunol,2011,11(11):723-737.
31 Colegio OR,Chu NQ,Szabo AL,et al.Functional polarization of tumour-associated macrophages by tumour-derived lactic acid [J].Nature,2014,513(7519):559-5563.
32 Ireland L,Santos A,Ahmed MS,et al.Chemoresistance in pancreatic cancer is driven by Stroma-Derived Insulin-Like growth factors [J].Cancer Res,2016,76(23):6851-6863.
33 Kuwada K,Kagawa S.The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer [J].J Exp Clin Cancer Res,2018,37(1):307.
34 Zhang M,Yan L,WANG GJ.Resistin effects on pancreatic cancer progression and chemoresistance are mediated through its receptors CAP1 and TLR4 [J].J Cell Physiol,2019,234(6):9457-9466.
35 Xian G,Zhao J,Qin C,et al.Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-beta1/Gfi-1 axis [J].Cancer Letters,2017,385:65-74.
36 Sierra-filardi E,Nieto C,Dominguez-soto A,et al.CCL2 shapes macrophage polarization by GM-CSF and M-CSF:identification of CCL2/CCR2-dependent gene expression profile [J].J Immunology (Baltimore,Md :1950),2014,192(8):3858-3867.
37 Brana I,Calles A,Lorusso PM,et al.Carlumab,an anti-C-C chemokine ligand 2 monoclonal antibody,in combination with four chemotherapy regimens for the treatment of patients with solid tumors:an open-label,multicenter phase 1b study [J].Targeted Oncol,2015,10(1):111-123.
38 Sanford DE,Belt BA,Panni RZ,et al.Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer:a role for targeting the CCL2/CCR2 axis [J].Clinical Cancer Res :J Ame Association for Cancer Res,2013,19(13):3404-3415.
39 Nywening TM,Wang-gillam A,Sanford DE,et al.Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer:a single-centre,open-label,dose-finding,non-randomised,phase 1b trial [J].The Lancet Oncol,2016,17(5):651-662.
40 Mitchem JB,Brennan DJ,Knolhoff BL,et al.Targeting tumor-infiltrating macrophages decreases tumor-initiating cells,relieves immunosuppression,and improves chemotherapeutic responses [J].Cancer Res,2013,73(3):1128:1141.
41 Prakash H,Nadella V,Singh S,et al.CD14/TLR4 priming potentially recalibrates and exerts anti-tumor efficacy in tumor associated macrophages in a mouse model of pancreatic carcinoma [J].Scientific Rep,2016,6:31490.
42 Zimmer SM,Liu J,Clayton JL,et al.Paclitaxel binding to human and murine MD-2 [J].J Biolog Chem,2008,283(41):27916-27926.
43 Okada KI,Hirono S,Kawai M,et al.Phase I Study of Nab-Paclitaxel plus Gemcitabine as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer [J].Anticancer Res,2017,37(2):853-858.
44 Hagemann T,Lawrence T,Mcneish I,et al."Re-educating" tumor-associated macrophages by targeting NF-kappaB [J].The Journal of experimental medicine,2008,205(6):1261-1268.
45 Wennhold K,Weber TM,Klein-gonzalez N,et al.CD40-activated B cells induce anti-tumor immunity in vivo [J].Oncotarget,2017,8(17):27740-27753.
46 Beatty GL,Chiorean EG,Fishman MP,et al.CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans [J].Science (New York,NY),2011,331(6024):1612:1616.
47 Rolny C,Mazzone M,Tugues S,et al.HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF [J].Cancer Cell,2011,19(1):31-44.
48 Kaneda MM,Cappello P,Nguyen AV,et al.Macrophage PI3Kgamma Drives Pancreatic Ductal Adenocarcinoma Progression [J].Cancer discovery,2016,6(8):870-885.
49 Yao L,Wang M,Niu Z,et al.Interleukin-27 inhibits malignant behaviors of pancreatic cancer cells by targeting M2 polarized tumor associated macrophages [J].Cytokine,2017,89:194-200.
50 Wang B,Zheng X,Liu J,et al.Osthole inhibits pancreatic cancer progression by directly exerting negative effects on cancer cells and attenuating tumor-infiltrating M2 macrophages [J].J Pharmacological Sci,2018,137(3):290-298.
51 Totiger TM,Srinivasan S,Jala VR,et al.Urolithin A,a novel natural compound to target PI3K/AKT/mTOR pathway in pancreatic cancer [J].Molecul Cancer Therapeut,2019,18(2):301-311.
基本信息:
DOI：10.13210/j.cnki.jhmu.20200414.001
中图分类号:R735.9
引用信息:
[1]王信琛,阴克强,马艳波.肿瘤相关巨噬细胞在胰腺癌中的研究进展[J].海南医学院学报,2020,26(23):1835-1840.DOI:10.13210/j.cnki.jhmu.20200414.001.
基金信息:
山西省重点研发计划项目(201903D321144)~~
2020-04-14
2020-04-14
2020-04-14